You Are Here » GastroEsophageal Reflux Disease - GERD » Children 1 to 11 Years Old
GastroEsophageal Reflux Disease - GERD
Contents of this Article
Children 1 to 11 Years Old
Nexium is Approved for Children 1 to 11 Years Old
On Feb. 28, 2008, the U.S. Food and Drug Administration (FDA) announced its approval of the short-term use of Nexium in children 1 to 11 years old for the treatment of gastroesophageal reflux disease (GERD). The agency approved Nexium in two forms: delayed-release capsule and liquid.
Nexium is approved in 10 milligrams (mg) or 20 mg daily for children 1 to 11 years old compared to 20 mg or 40 mg recommended for pediatric patients 12 to 17 years of age.
"This approval provides important information for appropriate dosing for children ages 1 thru 11 years with GERD," says Julie Beitz, M.D., Director of the Office of Drug Evaluation III in FDA's Center for Drug Evaluation and Research. "Children prescribed this drug should be monitored by their physicians for any adverse drug reactions."
What is Nexium?
Nexium - esomeprazole magnesium - is part of a class of drugs known as proton pump inhibitors (PPIs). These drugs decrease the amount of acid produced in the stomach and help heal erosions in the lining of the esophagus known as erosive esophagitis. Nexium is manufactured by AstraZeneca of Wilmington, Delaware.
Dosages Included in This Approval
Nexium is approved for short-term use in 10 milligrams (mg) or 20 mg daily for children ages 1 to 11 years old - compared to 20 mg or 40 mg recommended for pediatric (having to do with children) patients 12 to 17 years old.
What Did FDA Base This Approval On?
FDA based this approval on the extrapolation of data from previous study results in adults to the pediatric population, as well as safety and pharmacokinetic studies performed in pediatric patients. Pharmacokinetic studies show how our bodies absorb, distribute, metabolize, and excrete drugs.
In one study, 109 patients, ages 1 to 11 years old who had been diagnosed with GERD, were treated with Nexium once a day for up to eight weeks to evaluate its safety and tolerability. Most of these patients demonstrated healing of their esophageal erosions after eight weeks of treatment.
The Most Common Adverse Reactions in Children Treated With Nexium
- Headache
- Diarrhea
- Abdominal pain
- Nausea
- Gas
- Constipation
- Dry mouth
- Sleepiness
Using Nexium in Children Younger Than 1 Year
The safety and effectiveness of Nexium has not been established in children less than one year old.
Back To Top
References:
U.S. Food and Drug Administration
March 3, 2008
www.fda.gov
|